Skip to search.
 FTSE 100 Up 3.08%

More On MDABY

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Meda AB (MDABY)

-Other OTC
16.94 Down 0.16(0.92%) 12 Feb 20:07
Prev Close:17.10
Open:17.05
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.36467
Next Earnings Date:N/A
Day's Range:16.94 - 17.12
52wk Range:0.03 - 17.29
Volume:2,718
Avg Vol (3m):26,382
Market Cap:6.19b
P/E (ttm):102.68
EPS (ttm):0.17
Div & Yield:0.30 (1.76%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.66
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Meda AB operates as a specialty pharmaceutical company worldwide. It manufactures and sells specialty pharmaceutical products, branded generics, over-the-counter drugs, and other products in various therapy areas, such as respiratory, dermatology,... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback